1999 Fiscal Year Final Research Report Summary
Blood Pressure Control by the Angiotensin Metabolites and the application to a Functional Food Design.
| Project/Area Number |
10660128
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Single-year Grants |
|---|
| Section | 一般 |
|---|
| Research Field |
食品科学・栄養科学
|
|---|
| Research Institution | KYUSHU UNIVERSITY |
|---|
Principal Investigator |
MATSUI Toshiro Faculty of Agriculture, Kyushu University, Assistant Professor, 農学部, 助手 (20238942)
|
|---|
| Project Period (FY) |
1998 – 1999
|
| Keywords | Hypertenstion / Angiotensin metabolites / Antihypertensive effect / Renin-angiotensin system |
|---|
| Research Abstract |
In order to elucidate the depressor effect of endogenous angiotensin (Ang) metabolites, we have investigated the metabolic behavior of Angs, especially Ang (3-4), by using TSUKUBA-Hypertensive Rat (THM) and normotensive human plasma. The concentration of Angs in plasma was determined by our proposed fluorometric column-switching HPLC method with 2, 3-naphthalene-dealdehyde. As a result of the determination of Ang (3-4) in THM (12weeks), the level (426 fmol/ml-plasma) was 2-fold higher than that of wild type rat (207 fmol/ml-plasma). However, the increment was much lower than the increments of other Angs (Ang I : THM, 2247 fmol/ml-plasma ; WTR ; 530 fmol/ml-plasma, ANG II : THM, 143 fmol/ml-plasma ; WTR ; 53 fmol/ml-plasma). This result indicates that the blood pressure (BP) promotion would correlate with the metabolism of Ang (3-4), which is in good agreement of the results obtained in human subjects. Namely, BP increased with the decrease in the metabolic level of Ang (3-4) in human plasma. In addition, I have clarified that the absorption of exogenous Ang (3-4) was observed immediately after oral administration of it with the dose of 3, 6, 12 mg/drink. The maximum absorption was observed after 2hr, and the level decreased to the normal level within 8 hr after the administration (t1/2 : 3.1 hr). No BP reduction was observed in normotensive human subjects with the dosage of 6 mg Ang (3-4), while the BP of mild hypertensive human subjects decreased (9.5 mmHg) siginificantly (p<0.001). In addition, about 20 mmHg BP reduction of THM by single oral administration of Ang (3-4) (0.1 mg/g mouse) was observed after 1 hr. Consequently, these findings strongly led to the suggestion that endogenous Ang (3-4) may act as a depressor peptide towards the inhibition of circulating renin-angiotensin system.
|
